Chip-based analysis of myocordial infarction

Chip-based Analysis of Myocordial Infarction

Myocardial infarction (MI) is an acute life-threatening disease with a high global incidence. Today several protein biomarkers are used as target molecules for early diagnosis of MI, but the results are not always easy and clear to interpret. In cooperation with the Fraunhofer Institute ENAS Chemnitz we currently try to develop a Chip-based MI diagnosis tool which is based on the disease-associated lectin-binding capacity of red blood cells (RBC) and an integrated RBC-stability measurement. The new detection method may allow for the first time a differentiation of subgroups of MI in a considerably wider diagnosis window. We aim to differentiate between infarction and non-infarction or non-ischemic occlusion patients to replace in the latter case an unnecessary risky catheterization, and furthermore to increase the compliance.

Group Members

Dr. Jürgen Flemmig


Dr. Susanne Melzer
University of Leipzig, Leipzig, Germany


Sascha Geidel
Fraunhofer Institute for Electronic Nano Systems (ENAS), Chemnitz, Germany



letzte Änderung: 24.05.2017